fluorescein has been researched along with diclofenac in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Kraff, MC; McGuigan, L; Raanan, MG; Sanders, DR | 1 |
| Ward, DA | 1 |
| Andreu, D; Costa, J; Martínez, M; Notivol, R; Salvá, P | 1 |
| Cecchini, P; Pedio, M; Ravalico, G; Sanguinetti, G; Tognetto, D | 1 |
| Aragona, P; Ferreri, F; Mobrici, M; Stilo, A | 1 |
| Egea, MA; García, ML; Valls, O; Valls, R | 1 |
| Borecki, A; de Bruyn, JR; Gillies, ER; Harrison, TD; Hopkins, CC; Ragogna, PJ; Yunyaeva, O | 1 |
4 trial(s) available for fluorescein and diclofenac
| Article | Year |
|---|---|
Inhibition of blood-aqueous humor barrier breakdown with diclofenac. A fluorophotometric study.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Aqueous Humor; Blood; Diclofenac; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorescein; Fluoresceins; Fluorophotometry; Humans; Inflammation; Lenses, Intraocular; Male; Middle Aged; Postoperative Care; Prednisolone; Randomized Controlled Trials as Topic | 1990 |
Tolerability and safety of 0.1% diclofenac plus 0.3% tobramycin fixed-dose ophthalmic solution: a randomized, comparative, controlled study in healthy volunteers.
Topics: Adolescent; Adult; Conjunctiva; Cross-Over Studies; Diclofenac; Double-Blind Method; Drug Combinations; Eye Injuries; Female; Fluorescein; Humans; Hyperemia; Intraocular Pressure; Irritants; Male; Middle Aged; Ophthalmic Solutions; Retina; Tobramycin; Visual Acuity | 1999 |
Comparative evaluation of corneal epithelial permeability after the use of diclofenac 0.1% and flurbiprofen 0.03% after phacoemulsification.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Diclofenac; Epithelial Cells; Female; Fluorescein; Fluorophotometry; Flurbiprofen; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Permeability; Phacoemulsification; Prospective Studies | 2001 |
Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Diclofenac; Dry Eye Syndromes; Epithelium, Corneal; Eye Diseases; Female; Fluorescein; Humans; Indomethacin; Male; Middle Aged; Ophthalmic Solutions; Sensation; Single-Blind Method; Sjogren's Syndrome; Statistics, Nonparametric; Treatment Outcome | 2005 |
3 other study(ies) available for fluorescein and diclofenac
| Article | Year |
|---|---|
Comparative efficacy of topically applied flurbiprofen, diclofenac, tolmetin, and suprofen for the treatment of experimentally induced blood-aqueous barrier disruption in dogs.
Topics: Animals; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Blood-Aqueous Barrier; Diclofenac; Dogs; Eye; Fluorescein; Fluoresceins; Fluorophotometry; Flurbiprofen; Ocular Physiological Phenomena; Ophthalmic Solutions; Random Allocation; Suprofen; Tolmetin | 1996 |
Validation of a device for transcorneal drug permeation measure.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Diclofenac; Dose-Response Relationship, Drug; Equipment Design; Fluorescein; Fluorescent Dyes; Permeability; Rabbits; Reproducibility of Results | 2008 |
Phosphonium Polyelectrolyte Complexes for the Encapsulation and Slow Release of Ionic Cargo.
Topics: Adenosine Triphosphate; Animals; Cell Line; Diclofenac; Drug Carriers; Drug Liberation; Fluorescein; Hyaluronic Acid; Hydrophobic and Hydrophilic Interactions; Mice; Microscopy, Electron, Scanning; Myoblasts; Organophosphorus Compounds; Polyelectrolytes; Polymers; Rheology; Toxicity Tests; Ultracentrifugation | 2020 |